Skip to main content

Table 3 EQ-5D-3L in the overall sample and by anxiety and depression sub-groups

From: The performance of the EQ-5D-3L in screening for anxiety and depressive symptoms in hospital and community settings

 

Hospital setting

Community setting

EQ-5D-3L Components

Mean ± SD or N (%)

N

Anxiety/depression dimension

Index Score

VAS

N

Anxiety/depression dimension

Index Score

VAS

Level 1

Level 2

Level 3

Level 1

Level 2

Level 3

Overall

492

284 (57.5)

180 (36.4)

29 (5.9)

0.69 ± 0.21

63.4 ± 18.9

400

294 (73.1)

92 (22.9)

16 (4.0)

0.77 ± 0.22

71.4 ± 19.4

Anxiety and Any Depression Sub-Groups

            

 No anxiety nor any depressive symptomsa

292

221 (75.7)

66 (22.6)

5 (1.7)

0.75 ± 0.20

66.9 ± 17.1

310

264 (85.2)

44 (14.2)

2 (0.7)

0.79 ± 0.20

75.5 ± 16.9

 Anxiety present, no depressive symptomsb

64

28 (43.8)

34 (53.1)

2 (3.1)

0.63 ± 0.21

59.2 ± 18.5

23

11 (47.8)

8 (34.8)

4 (17.4)

0.62 ± 0.24

51.7 ± 23.7

 Any depressive symptoms, no anxietyc

52

16 (31.4)

28 (54.9)

7 (13.7)

0.64 ± 0.22

63.7 ± 21.3

41

15 (36.6)

22 (53.7)

4 (9.8)

0.63 ± 0.21

64.2 ± 17.6

 Anxiety and any depressive symptomsd

84

18 (21.7)

50 (60.2)

15(18.1)

0.59 ± 0.20

54.6 ± 20.5

26

2 (7.7)

18 (69.2)

6 (23.1)

0.44 ± 0.26

52.8 ± 21.9

 P value

 

< 0.001

 0.137

< 0.001

 

< 0.001

 <0.001

 <0.001

Anxiety and Moderate-Severe Depression Sub-Groups

            

 No anxiety or moderate-severe depressive symptomse

346

244 (70.5)

96 (27.8)

6 (1.7)

0.73 ± 0.20

65.6 ± 17.5

329

273 (83.0)

51 (15.5)

5 (1.5)

0.78 ± 0.21

74.2 ± 18.0

 Anxiety present, no moderate-severe depressive symptomsf

10

5 (50.0)

4 (40.0)

1 (10.0)

0.57 ± 0.23

63.2 ± 21.1

4

2 (50.0)

1 (25.0)

1 (25.0)

0.59 ± 0.34

44.3 ± 29.6

 Moderate-severe depressive symptoms, no anxietyg

83

24 (29.3)

45 (54.9)

13 (15.9)

0.64 ± 0.21

62.8 ± 21.0

57

17 (29.8)

34 (59.7)

6 (10.5)

0.59 ± 0.23

61.7 ± 17.5

 Anxiety and moderate-severe depressive symptomsh

53

10 (19.2)

33 (63.5)

9 (17.3)

0.57 ± 0.21

50.7 ± 19.6

10

0 (0.0)

6 (60.0)

4 (40.0)

0.35 ± 0.26

49.0 ± 29.6

 P value

 

< 0.001

 0.003

< 0.001

 

< 0.001

 <0.001

 <0.001

  1. aGAD-2 < 3 and PHQ-9 < 10; bGAD-2 ≥ 3 and PHQ-9 < 10; cGAD-2 < 3 and PHQ-9 ≥ 10; dGAD-2 ≥ 3 and PHQ-9 ≥ 10
  2. eGAD-2 < 3 and PHQ-9 < 15; fGAD-2 < 3 and PHQ-9 ≥ 15; gGAD-2 ≥ 3 and PHQ-9 < 15; hGAD-2 ≥ 3 and PHQ-9 ≥ 15
Back to article page

Health and Quality of Life Outcomes

ISSN: 1477-7525

Contact us